Merit Medical Systems (MMSI) Cash from Financing Activities (2010 - 2026)

Merit Medical Systems has reported Cash from Financing Activities for 17 years, with the latest figure at $948000.0 in Q2 2026.

• Quarterly Cash from Financing Activities fell 78.19% year-over-year to $948000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$644000.0 (up 98.1% YoY) and the FY2025 annual result came in at $16.0 million, up 126.66% from the prior year.
• Cash from Financing Activities grew to $948000.0 in Q2 2026 per MMSI's latest filing, from -$6.3 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $472.8 million in Q4 2023 and troughed at -$54.6 million in Q3 2023.
• A 5-year average of $25.0 million and a median of -$431000.0 in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 8324.21% in 2023, then plunged 3522.33% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$5.7 million in 2022, then soared by 8324.21% to $472.8 million in 2023, then slumped by 99.49% to $2.4 million in 2024, then soared by 108.14% to $5.1 million in 2025, then sank by 81.27% to $948000.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $948000.0, -$6.3 million, and $5.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.